Phytoagents for cancer management: Regulation of nucleic acid oxidation, ROS, and related mechanisms

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Lee, Wai Leng ^a   Huang, Jing Ying ^b   Shyur, Lie Fen ^b,c,d  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CELL DEATH; DISEASES; FREE RADICALS; GENES; METAL IONS; NUCLEIC ACIDS;

CANCER DEVELOPMENT; CANCER PROGRESSION; EXPERIMENTAL EVIDENCE; GENOME INSTABILITY; GENOMIC INSTABILITY; METAL-ION CHELATION; OXIDATIVE DNA DAMAGE; REACTIVE OXYGEN SPECIES;

OXIDATION;

ANTIOXIDANT; ARTEMISININ; CURCUMIN; DIALLYL DISULFIDE; DNA BASE; ELECTROPHILE; EPIGALLOCATECHIN GALLATE; FLAVONOID; GENISTEIN; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON CHELATING AGENT; METAL ION; NITRIC OXIDE; NUCLEIC ACID; PARTHENOLIDE; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; RESVERATROL; SESQUITERPENE LACTONE; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2; TRANSITION ELEMENT; VITAMIN;

AIR POLLUTANT; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CHELATION; CHEMOPROPHYLAXIS; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRUCTURE; DNA SYNTHESIS; ELECTROPHILICITY; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FATTY ACID OXIDATION; FENTON REACTION; GENE EXPRESSION; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; HUMAN; INFLAMMATION; IONIZING RADIATION; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHYSIOLOGICAL PROCESS; POINT MUTATION; PROTEIN DENATURATION; REGULATORY MECHANISM; SENESCENCE; ULTRAVIOLET RADIATION; ANIMAL; DRUG EFFECT; METABOLISM; NEOPLASM; PHYTOTHERAPY; REVIEW;

ANIMALS; HUMANS; NEOPLASMS; NUCLEIC ACIDS; OXIDATION-REDUCTION; PHYTOCHEMICALS; PHYTOTHERAPY; REACTIVE OXYGEN SPECIES;

EID: 84896258134     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/925804     Document Type: Article

References (189)

1. Wolters S., Schumacher B., Genome maintenance and transcription integrity in aging and disease. Frontiers in Genetics 2013 4 article 19 10.3389/fgene.2013.00019
2. Yin H., Xu L., Porter N. A., Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews 2011 111 10 5944 5972 2-s2.0-80054089650 10.1021/cr200084z
3. Grimm S., Höhn A., Grune T., Oxidative protein damage and the proteasome. Amino Acids 2012 42 1 23 38 2-s2.0-79959534486 10.1007/s00726-010- 0646-8
4. Dizdaroglu M., Jaruga P., Birincioglu M., Rodriguez H., Free radical-induced damage to DNA: mechanisms and measurement. Free Radical Biology and Medicine 2002 32 11 1102 1115 2-s2.0-0036591855 10.1016/S0891-5849(02)00826- 2 (Pubitemid 34603348)
5. Maynard S., Schurman S. H., Harboe C., de Souza-Pinto N. C., Bohr V. A., Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009 30 1 2 10 2-s2.0-58949084649 10.1093/carcin/bgn250
6. Shaheen M., Shanmugam I., Hromas R., The role of PCNA posttranslational modifications in translesion synthesis. Journal of Nucleic Acids 2010 2010 8 761217 10.4061/2010/761217
7. Jones S., Chen W.-D., Parmigiani G., Diehl F., Beerenwinkel N., Antal T., Traulsen A., Nowak M. A., Siegel C., Velculescu V. E., Kinzler K. W., Vogelstein B., Willis J., Markowitz S. D., Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America 2008 105 11 4283 4288 2-s2.0-41949139438 10.1073/pnas.0712345105 (Pubitemid 351754372)
8. Valavanidis A., Vlachogianni T., Fiotakis C., 8-hydroxy-2′- deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health: Part C 2009 27 2 120 139 2-s2.0-66149088854 10.1080/10590500902885684
9. Lagadu S., Lechevrel M., Sichel F., Breton J., Pottier D., Couderc R., Moussa F., Prevost V., 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST. Journal of Experimental and Clinical Cancer Research 2010 29 157 1756 9966 2-s2.0-78649717947 10.1186/1756-9966-29-157
10. Bartsch H., Nair J., Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detection and Prevention 2004 28 6 385 391 2-s2.0-9644294192 10.1016/j.cdp.2004.07.004 (Pubitemid 39568933)
11. Wang M., Dhingra K., Hittelman W. N., Liehr J. G., De Andrade M., Li D., Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiology Biomarkers and Prevention 1996 5 9 705 710 2-s2.0-0029835149 (Pubitemid 26304645)
12. Kaur S., Greaves P., Cooke D. N., Edwards R., Steward W. P., Gescher A. J., Marczylo T. H., Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts. Journal of Agricultural and Food Chemistry 2007 55 9 3378 3385 2-s2.0-34249308188 10.1021/jf0633342 (Pubitemid 46806551)
13. Machowetz A., Poulsen H. E., Gruendel S., Weimann A., Fitó M., Marrugat J., De La Torre R., Salonen J. T., Nyyssönen K., Mursu J., Nascetti S., Gaddi A., Kiesewetter H., Bäumler H., Selmi H., Kaikkonen J., Zunft H.-J. F., Covas M.-I., Koebnick C., Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. The FASEB Journal 2007 21 1 45 52 2-s2.0-33845992189 10.1096/fj.06-6328com (Pubitemid 46052544)
14. Birben E., Sahiner U. M., Sackesen C., Erzurum S., Kalayci O., Oxidative stress and antioxidant defense. World Allergy Organization Journal 2012 5 1 9 19 2-s2.0-84857274709 10.1097/WOX.0b013e3182439613
15. Surh Y.-J., Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 2003 3 10 768 780 2-s2.0-0142166328 (Pubitemid 37328815)
16. Antonenkov V. D., Grunau S., Ohlmeier S., Hiltunen J. K., Peroxisomes are oxidative organelles. Antioxidants and Redox Signaling 2010 13 4 525 537 2-s2.0-77954484645 10.1089/ars.2009.2996
17. Sun X., Ai M., Wang Y., Shen S., Gu Y., Jin Y., Zhou Z., Long Y., Yu Q., Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate. Journal of Biological Chemistry 2013 288 8826 8837 10.1074/jbc.M112.429316
18. Zanotto-Filho A., Schroder R., Moreira J. C. F., Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured Sertoli cells. Free Radical Research 2008 42 6 593 601 2-s2.0-46649108164 10.1080/10715760802144422 (Pubitemid 351935152)
19. Taibi G., Carruba G., Miceli V., Cocciadiferro L., Cucchiara A., Nicotra C. M. A., Sildenafil protects epithelial cell through the inhibition of xanthine oxidase and the impairment of ROS production. Free Radical Research 2010 44 2 232 239 2-s2.0-74549196355 10.3109/10715760903431426
20. Beak S. M., Lee Y. S., Kim J.-A., NADPH oxidase and cyclooxygenase mediate the ultraviolet B-induced generation of reactive oxygen species and activation of nuclear factor- B in HaCaT human keratinocytes. Biochimie 2004 86 7 425 429 2-s2.0-4143089319 10.1016/j.biochi.2004.06.010 (Pubitemid 39092705)
21. Matthias C., Schuster M. T., Zieger S., Harreus U., COX-2 inhibitors celecoxib and rofecoxib prevent oxidative DNA fragmentation. Anticancer Research 2006 26 3A 2003 2007 2-s2.0-33745617697 (Pubitemid 43989461)
22. Los M., Schenk H., Hexel K., Baeuerle P. A., Droge W., Schulze-Osthoff K., IL-2 gene expression and NF- B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO Journal 1995 14 15 3731 3740 2-s2.0-0029164695
23. Edderkaoui M., Hong P., Vaquero E. C., Lee J. K., Fischer L., Friess H., Buchler M. W., Lerch M. M., Pandol S. J., Gukovskaya A. S., Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. American Journal of Physiology Gastrointestinal and Liver Physiology 2005 289 6 G1137 G1147 2-s2.0-28444499374 10.1152/ajpgi.00197.2005 (Pubitemid 41740620)
24. Grimm M. J., Vethanayagam R. R., Almyroudis N. G., Dennis C. G., Khan A. N., D'auria A. C., Singel K. L., Davidson B. A., Knight P. R., Blackwell T. S., Hohl T. M., Mansour M. K., Vyas J. M., Röhm M., Urban C. F., Kelkka T., Holmdahl R., Segal B. H., Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. Journal of Immunology 2013 190 8 4175 4184 10.4049/jimmunol.1202800
25. Almyroudis N. G., Grimm M. J., Davidson B. A., Röhm M., Urban C. F., Segal B. H., NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Frontiers in Immunology 2013 4 article 45 10.3389/fimmu.2013.00045
26. Nussbaum C., Klinke A., Adam M., Baldus S., Sperandio M., Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxidants and Redox Signaling 2013 18 6 692 713 10.1089/ars.2012.4783
27. Tidén A.-K., Sjögren T., Svensson M., Bernlind A., Senthilmohan R., Auchère F., Norman H., Markgren P.-O., Gustavsson S., Schmidt S., Lundquist S., Forbes L. V., Magon N. J., Paton L. N., Jameson G. N., Eriksson H., Kettle A. J., 2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation. Journal of Biological Chemistry 2011 286 43 37578 37589 2-s2.0-80054798514 10.1074/jbc.M111.266981
28. Trinchieri G., Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annual Review of Immunology 2012 30 677 706 2-s2.0-84859401430 10.1146/annurev-immunol-020711-075008
29. Stohs S. J., Bagchi D., Oxidative mechanisms in the toxicity of metal ions. Free Radical Biology and Medicine 1995 18 2 321 336 2-s2.0-0028798434 10.1016/0891-5849(94)00159-H
30. Lee J. C., Son Y. O., Pratheeshkumar P., Shi X., Oxidative stress and metal carcinogenesis. Free Radical Biology and Medicine 2012 53 4 742 757 10.1016/j.freeradbiomed.2012.06.002
31. Sies H., Strategies of antioxidant defense. European Journal of Biochemistry 1993 215 2 213 219 2-s2.0-0027209389 10.1111/j.1432-1033.1993. tb18025.x (Pubitemid 23224303)
32. Arosio P., Levi S., Ferritin, iron homeostasis, and oxidative damage. Free Radical Biology and Medicine 2002 33 4 457 463 2-s2.0-0037101879 10.1016/S0891-5849(02)00842-0 (Pubitemid 34874967)
33. Wu W. S., Zhao Y. S., Shi Z. H., Chang S. Y., Nie G. J., Duan X. L., Zhao S.-M., Wu Q., Yang Z. -L., Zaho B. -L., Chang Y.-Z., Mitochondrial ferritin attenuates β -amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways. Antioxidants and Redox Signaling 2013 18 2 158 169 10.1089/ars.2011.4285
34. Luck A. N., Mason A. B., Transferrin-mediated cellular iron delivery. Current Topics Membranes 2012 69 3 35 10.1016/B978-0-12-394390-3.00001-X
35. Johannesson T., Kristinsson J., Torsdottir G., Snaedal J., Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD). Laeknabladid 2012 98 10 531 537
36. Qu W., Pi J., Waalkes M. P., Metallothionein blocks oxidative DNA damage in vitro. Archives of Toxicology 2013 87 2 311 321 10.1007/s00204-012-0927-y
37. Beutler E., Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 2008 111 1 16 24 2-s2.0-38049296 10.1182/blood-2007-04-077412
38. Kobayashi M., Yamamoto M., Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants and Redox Signaling 2005 7 3-4 385 394 2-s2.0-14044254798 10.1089/ars.2005.7.385 (Pubitemid 40279806)
39. Niture S. K., Khatri R., Jaiswal A. K., Regulation of Nrf2-an update. Free Radical Biology and Medicine 2013 10.1016/j.freeradbiomed.2013.02.008
40. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007 47 89 116 2-s2.0-33847050801 10.1146/annurev.pharmtox.46.120604.141046
41. Kim K. C., Kang K. A., Zhang R., Piao M. J., Kim G. Y., Kang M. Y., Lee S. J., Lee N. H., Surh Y.-J., Hyun J. W., Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt. International Journal of Biochemistry and Cell Biology 2010 42 2 297 305 2-s2.0-73749083990 10.1016/j.biocel.2009.11.009
42. Kaspar J. W., Niture S. K., Jaiswal A. K., Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biology and Medicine 2009 47 9 1304 1309 2-s2.0-70349843323 10.1016/j.freeradbiomed.2009.07.035
43. Kim J., Cha Y.-N., Surh Y.-J., A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutation Research 2010 690 1-2 12 23 2-s2.0-77955279350 10.1016/j.mrfmmm.2009.09.007
44. Kundu J. K., Surh Y.-J., Nrf2-keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharmaceutical Research 2010 27 6 999 1013 2-s2.0-77953228968 10.1007/s11095-010-0096-8
45. Na H.-K., Kim E.-H., Jung J.-H., Lee H.-H., Hyun J.-W., Surh Y.-J., (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Archives of Biochemistry and Biophysics 2008 476 2 171 177 2-s2.0-48049089409 10.1016/j.abb.2008.04.003
46. Knobel P. A., Marti T. M., Translesion DNA synthesis in the context of cancer research. Cancer Cell International 2011 11 39 2-s2.0-80055106773 10.1186/1475-2867-11-39
47. Sale J. E., Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harbor Perspectives in Biology 2013 5 3 10.1101/cshperspect.a012708
48. Benderoth M., Textor S., Windsor A. J., Mitchell-Olds T., Gershenzon J., Kroymann J., Positive selection driving diversification in plant secondary metabolism. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9118 9123 2-s2.0-33745159638 10.1073/pnas.0601738103 (Pubitemid 43902543)
49. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 2007 70 3 461 477 2-s2.0-34247109045 10.1021/np068054v (Pubitemid 46595760)
50. Pan L., Chai H., Kinghorn A. D., The continuing search for antitumor agents from higher plants. Phytochemistry Letters 2010 3 1 1 8 2-s2.0-77649235468 10.1016/j.phytol.2009.11.005
51. Singh S., From exotic spice to modern drug? Cell 2007 130 5 765 768 2-s2.0-34548227773 10.1016/j.cell.2007.08.024 (Pubitemid 47332578)
52. Harvey A. L., Natural products in drug discovery. Drug Discovery Today 2008 13 19-20 894 901 2-s2.0-52049109838 10.1016/j.drudis.2008.07.004
53. Li J. W.-H., Vederas J. C., Drug discovery and natural products: end of an era or an endless frontier? Science 2009 325 5937 161 165 2-s2.0-67650436176 10.1126/science.1168243
54. Lee W.-L., Shiau J.-Y., Shyur L.-F., Taxol, camptothecin and beyond for cancer therapy. Advances in Botanical Research 2012 62 133 178 10.1016/B978-0-12-394591-4.00008-8
55. Hsan K. M., Chen C.-C., Shyur L.-F., Current research and development of chemotherapeutic agents for melanoma. Cancers 2010 2 2 397 419 2-s2.0-79952268979 10.3390/cancers2020397
56. Antoslewicz J., Ziolkowski W., Kar S., Powolny A. A., Singh S. V., Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Medica 2008 74 13 1570 1579 2-s2.0-56249114165 10.1055/s-2008-1081307
57. Neves A. R., Lucio M., Lima J. L. C., Reis S., Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Current Medicinal Chemistry 2012 19 11 1663 1681 2-s2.0-84860540855 10.2174/092986712799945085
58. Li H.-Q., Luo Y., Qiao C.-H., The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone. Mini-Reviews in Medicinal Chemistry 2012 12 4 350 362 2-s2.0-84858330813 10.2174/138955712799829258
59. López-Lázaro M., Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Molecular Nutrition and Food Research 2008 52 supplement 1 S103 S127 2-s2.0-53449094405 10.1002/mnfr. 200700238
60. Lambert J. D., Elias R. J., The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Archives of Biochemistry and Biophysics 2010 501 1 65 72 2-s2.0-77956178353 10.1016/j.abb.2010.06.013
61. Lee W.-L., Wen T.-N., Shiau J.-Y., Shyur L.-F., Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells. Journal of Proteome Research 2010 9 1 237 253 2-s2.0-73649090040 10.1021/pr900543e
62. Huang C.-C., Lo C.-P., Chiu C.-Y., Shyur L.-F., Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice. British Journal of Pharmacology 2010 159 4 856 871 2-s2.0-77249177609 10.1111/j.1476-5381.2009.00581.x
63. Lee W.-L., Shyur L.-F., Deoxyelephantopin impedes mammary adenocarcinoma cell motility by inhibiting calpain-mediated adhesion dynamics and inducing reactive oxygen species and aggresome formation. Free Radical Biology and Medicine 2012 52 8 1423 1436 2-s2.0-84859006576 10.1016/j.freeradbiomed.2012.01. 020
64. Efferth T., Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Current Drug Targets 2006 7 4 407 421 2-s2.0-33646024956 10.2174/138945006776359412 (Pubitemid 43744832)
65. Kim S. L., Trang K. T., Kim S. H., Kim I. H., Lee S. O., Lee S. T., Kim D. G., Kim S. W., Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis. International Journal of Oncology 2012 41 4 10.3892/ijo.2012.1587
66. Oka D., Nishimura K., Shiba M., Nakai Y., Arai Y., Nakayama M., Takayama H., Inoue H., Okuyama A., Nonomura N., Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF- B. International Journal of Cancer 2007 120 12 2576 2581 2-s2.0-34247525963 10.1002/ijc.22570 (Pubitemid 46651277)
67. Sweeney C. J., Mehrotra S., Sadaria M. R., Kumar S., Shortle N. H., Roman Y., Sheridan C., Campbell R. A., Murry D. J., Badve S., Nakshatri H., The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Molecular Cancer Therapeutics 2005 4 6 1004 1012 2-s2.0-21344454493 10.1158/1535-7163.MCT-05-0030 (Pubitemid 40909083)
68. Lee K. W., Bode A. M., Dong Z., Molecular targets of phytochemicals for cancer prevention. Nature Reviews Cancer 2011 11 3 211 218 2-s2.0-79952012742 10.1038/nrc3017
69. Mandel S. A., Amit T., Kalfon L., Reznichenko L., Weinreb O., Youdim M. B., Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). Journal of Alzheimer's Disease 2008 15 2 211 222 2-s2.0-54249143535
70. Hider R. C., Liu Z. D., Khodr H. H., Metal chelation of polyphenols. Methods in Enzymology 2001 335 190 203 2-s2.0-0034986370 10.1016/S0076-6879(01) 35243-6 (Pubitemid 32507238)
71. Hayes J. D., McMahon M., Chowdhry S., Dinkova-Kostova A. T., Cancer chemoprevention mechanisms mediated through the keap1-Nrf2 pathway. Antioxidants and Redox Signaling 2010 13 11 1713 1748 2-s2.0-77958130983 10.1089/ars.2010.3221
72. Gerhäuser C., Klimo K., Heiss E., Neumann I., Gamal-Eldeen A., Knauft J., Liu G.-Y., Sitthimonchai S., Frank N., Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutation Research 2003 523-524 163 172 2-s2.0-0037294150 10.1016/S0027-5107(02)00332-9 (Pubitemid 36293243)
73. Papa S., Bubici C., Pham C. G., Zazzeroni F., Franzoso G., NF- B meets ROS: an "iron-ic" encounter. Cell Death and Differentiation 2005 12 10 1259 1262 2-s2.0-27144526668 10.1038/sj.cdd.4401694 (Pubitemid 41486096)
74. Meng Z., Yan C., Deng Q., Gao D. F., Niu X. L., Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF- B pathways. Acta Pharmacologica Sinica 2013 34 7 901 911 10.1038/aps.2013.24
75. Qi S., Xin Y., Guo Y., Diao Y., Kou X., Luo L., Yin Z., Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF- B signaling pathways. International Immunopharmacology 2012 12 1 278 287 2-s2.0-84856091690 10.1016/j.intimp.2011.12.001
76. 2NF- B signaling pathway in vascular endothelial inflammation. Molecular and Cellular Biochemistry 2012 359 1-2 183 191 2-s2.0-83555173312 10.1007/s11010-011-1013-0
77. Yang C., Yang Z., Zhang M., Dong Q., Wang X., Lan A., Zeng F., Chen P., Wang C., Feng J., Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in hacat cells through inhibition of ROS/NF- B/COX-2 pathway. PLoS One 2011 6 7 2-s2.0-79960320543 10.1371/journal.pone. 0021971 e21971
78. Box H. C., Patrzyc H. B., Budzinski E. E., Dawidzik J. B., Freund H. G., Zeitouni N. C., Mahoney M. C., Profiling oxidative DNA damage: effects of antioxidants. Cancer Science 2012 103 11 2002 2006 10.1111/j.1349-7006.2012. 02391
79. Farias M. S., Budni P., Ribeiro C. M., Parisotto E. B., Santos C. E., Dias J. F., Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. Gastroenterología y Hepatología 2012 35 6 386 394 10.1016/j.gastrohep.2012.03.004
80. Singh N., Bhardwaj P., Pandey R. M., Saraya A., Oxidative stress and antioxidant capacity in patients with chronic pancreatitis with and without diabetes mellitus. Indian Journal of Gastroenterology 2012 31 5 226 231 10.1007/s12664-012-0236-7
81. Puertollano M. A., Puertollano E., De Cienfuegos G. A., De Pablo M. A., Dietary antioxidants: immunity and host defense. Current Topics in Medicinal Chemistry 2011 11 14 1752 1766 2-s2.0-79959929009 10.2174/156802611796235107
82. McCall M. R., Frei B., Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radical Biology and Medicine 1999 26 7-8 1034 1053 2-s2.0-0032921559 10.1016/S0891-5849(98)00302-5 (Pubitemid 29198377)
83. Myung S.-K., Kim Y., Ju W., Choi H. J., Bae W. K., Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials. Annals of Oncology 2010 21 1 166 179 2-s2.0-77949317645 10.1093/annonc/mdp286 mdp286
84. Chang Y. J., Myung S.-K., Chung S. T., Kim Y., Lee E.-H., Jeon Y.-J., Park C.-H., Seo H. G., Huh B. Y., Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: a meta-analysis of randomized controlled trials. Dermatology 2011 223 1 36 44 2-s2.0-80053985339 10.1159/000329439
85. Mosby T. T., Cosgrove M., Sarkardei S., Platt K. L., Kaina B., Nutrition in adult and childhood cancer: role of carcinogens and anti-carcinogens. Anticancer Research 2012 32 10 4171 4192
86. Cheung F. S., Lovicu F. J., Reichardt J. K., Current progress in using vitamin D and its analogs for cancer prevention and treatment. Expert Review of Anticancer Therapy 2012 12 6 811 837 10.1586/era.12.53
87. Garland C. F., French C. B., Baggerly L. L., Heaney R. P., Vitamin D supplement doses and serum 25-Hydroxyvitamin D in the range associated with cancer prevention. Anticancer Research 2011 31 2 607 612 2-s2.0-79953251909
88. Gaziano J. M., Sesso H. D., Christen W. G., Bubes V., Smith J. P., Macfadyen J., Schvartz M., Manson J. E., Glynn R. J., Buring J. E., Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. The Journal of the American Medical Association 2012 308 18 1871 1880 2-s2.0-58149375890
89. Sram R. J., Farmer P., Singh R., Garte S., Kalina I., Popov T. A., Binkova B., Ragin C., Taioli E., Effect of vitamin levels on biomarkers of exposure and oxidative damage-the EXPAH study. Mutation Research 2009 672 2 129 134 2-s2.0-58649124071 10.1016/j.mrgentox.2008.11.005
90. Yan Y., Yang J.-Y., Mou Y.-H., Wang L.-H., Zhou Y.-N., Wu C.-F., Differences in the activities of resveratrol and ascorbic acid in protection of ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Food and Chemical Toxicology 2012 50 2 168 174 2-s2.0-84855242085 10.1016/j.fct.2011.10. 046
91. Collins B. H., Horská A., Hotten P. M., Riddoch C., Collins A. R., Kiwifruit protects against oxidative DNA damage in human cells and in vitro. Nutrition and Cancer 2001 39 1 148 153 2-s2.0-0034824951 (Pubitemid 32880960)
92. Fiorentino A., D'abrosca B., Pacifico S., Mastellone C., Scognamiglio M., Monaco P., Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits. Journal of Agricultural and Food Chemistry 2009 57 10 4148 4155 2-s2.0-66149083910 10.1021/jf900210z
93. Kapiszewska M., Soltys E., Visioli F., Cierniak A., Zajac G., The protective ability of the Mediterranean plant extracts against the oxidative DNA damage. The role of the radical oxygen species and the polyphenol content. Journal of Physiology and Pharmacology 2005 56 supplement 1 183 197 2-s2.0-33748186915 (Pubitemid 44922304)
94. Viladomiu M., Hontecillas R., Lu P., Bassaganya-Riera J., Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evidence-Based Complementary and Alternative Medicine 2013 2013 18 789764 10.1155/2013/789764
95. Jurenka J., Therapeutic applications of pomegranate (Punica granatum L.): a review. Alternative Medicine Review 2008 13 2 128 144 2-s2.0-47549111139 (Pubitemid 352009502)
96. Bishayee A., Bhatia D., Thoppil R. J., Darvesh A. S., Nevo E., Lansky E. P., Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 2011 32 6 888 896 2-s2.0-79958214540 10.1093/carcin/bgr045
97. Thoppil R. J., Bhatia D., Barnes K. F., Haznagy-Radnai E., Hohmann J., Darvesh A. S., Bishayee A., Black currant anthocyanins abrogate oxidative stress through Nrf2- mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma. Currant Cancer Drug Targets 2012 12 9 1244 1257
98. Romagnolo D. F., Selmin O. I., Flavonoids and cancer prevention: a review of the evidence. Journal of Nutrition in Gerontology and Geriatrics 2012 31 3 206 238 10.1080/21551197.2012.702534
99. Hayes J. D., McMahon M., Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Letters 2001 174 2 103 113 2-s2.0-0035965945 10.1016/S0304-3835(01)00695-4 (Pubitemid 33026113)
100. Na H.-K., Surh Y.-J., Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food and Chemical Toxicology 2008 46 4 1271 1278 2-s2.0-39249085843 10.1016/j.fct.2007.10.006
101. Surh Y.-J., Kundu J. K., Na H.-K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica 2008 74 13 1526 1539 2-s2.0-56249106571 10.1055/s-0028-1088302
102. Platet N., Cathiard A. M., Gleizes M., Garcia M., Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Critical Reviews in Oncology/Hematology 2004 51 1 55 67 2-s2.0-2942676455 10.1016/j.critrevonc.2004.02.001 (Pubitemid 38781751)
103. Lee A. J., Cai M. X., Thomas P. E., Conney A. H., Zhu B. T., Characterization of the oxidative metabolites of 17 β -estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 2003 144 8 3382 3398 2-s2.0-0042315387 10.1210/en.2003-0192 (Pubitemid 36904414)
104. Aiyer H. S., Vadhanam M. V., Stoyanova R., Caprio G. D., Clapper M. L., Gupta R. C., Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genes. International Journal of Molecular Sciences 2008 9 3 327 341 2-s2.0-41649085767 10.3390/ijms9030327 (Pubitemid 351482118)
105. Aiyer H. S., Kichambare S., Gupta R. C., Prevention of oxidative DNA damage by bioactive berry components. Nutrition and Cancer 2008 60 supplement 1 36 42 2-s2.0-55949121894 10.1080/01635580802398448
106. Wondrak G. T., Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxidants and Redox Signaling 2009 11 12 3013 3069 2-s2.0-70449107252 10.1089/ars.2009.2541
107. Yang J.-C., Lu M.-C., Lee C.-L., Chen G.-Y., Lin Y.-Y., Chang F.-R., Wu Y.-C., Selective targeting of breast cancer cells through ROS-mediated mechanisms potentiates the lethality of paclitaxel by a novel diterpene, gelomulide K. Free Radical Biology and Medicine 2011 51 3 641 657 2-s2.0-79960004073 10.1016/j.freeradbiomed.2011.05.012
108. Trachootham D., Alexandre J., Huang P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 2009 8 7 579 591 2-s2.0-67650071137 10.1038/nrd2803
109. Bystrom L. M., Guzman M. L., Rivella S., Iron and reactive oxygen species: friends or foes of cancer cells? Antioxidants and Redox Signaling 2013 10.1089/ars.2012.5014
110. Calzolari A., Oliviero I., Deaglio S., Mariani G., Biffoni M., Sposi N. M., Malavasi F., Peschle C., Testa U., Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells, Molecules, and Diseases 2007 39 1 82 91 2-s2.0-34248564865 10.1016/j.bcmd.2007.02.003 (Pubitemid 46754920)
111. Daniels T. R., Bernabeu E., Rodríguez J. A., Patel S., Kozman M., Chiappetta D. A., Holler E., Ljubimova J. Y., Helguera G., Penichet M. L., The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochimica et Biophysica Acta 2012 1820 3 291 317 2-s2.0-84857371220 10.1016/j.bbagen.2011.07.016
112. You B. R., Kim S. Z., Kim S. H., Park W. H., Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Molecular and Cellular Biochemistry 2011 357 1-2 295 303 2-s2.0-84857408230
113. Chen G., Chen Z., Hu Y., Huang P., Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by β -phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxidants and Redox Signaling 2011 15 12 2911 2921 2-s2.0-80155134262 10.1089/ars.2011. 4170
114. Locatelli C., Leal P. C., Yunes R. A., Nunes R. J., Creczynski-Pasa T. B., Gallic acid ester derivatives induce apoptosis and cell adhesion inhibition in melanoma cells: the relationship between free radical generation, glutathione depletion and cell death. Chemico-Biological Interactions 2009 181 2 175 184 2-s2.0-68849100389 10.1016/j.cbi.2009.06.019
115. Piwocka K., Jaruga E., Skierski J., Gradzka I., Sikora E., Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free Radical Biology and Medicine 2001 31 5 670 678 2-s2.0-0035451195 10.1016/S0891-5849(01)00629-3 (Pubitemid 32777868)
116. Pandey M. K., Kumar S., Thimmulappa R. K., Parmar V. S., Biswal S., Watterson A. C., Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. European Journal of Pharmaceutical Sciences 2011 43 1-2 16 24 2-s2.0-79955701862 10.1016/j.ejps.2011.03.003
117. Yang C., Zhang X., Fan H., Liu Y., Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Research 2009 1282 133 141 2-s2.0-67649670106 10.1016/j.brainres.2009.05. 009
118. Kang E. S., Kim G. H., Kim H. J., Woo I. S., Ham S. A., Jin H., Kim M. Y., Kim H. J., Lee J. H., Chang K. C., Seo H. G., Hwang J.-Y., Nrf2 regulates curcumin-induced aldose reductase expression indirectly via nuclear factor- B. Pharmacological Research 2008 58 1 15 21 2-s2.0-50649108590 10.1016/j.phrs.2008. 05.009
119. Hou D.-X., Korenori Y., Tanigawa S., Yamada-Kato T., Nagai M., He X., He J., Dynamics of Nrf2 and Keap1 in ARE-mediated NQO1 expression by wasabi 6-(methylsulfinyl)hexyl isothiocyanate. Journal of Agricultural and Food Chemistry 2011 59 22 11975 11982 2-s2.0-81255138105 10.1021/jf2032439
120. Wagner A. E., Boesch-Saadatmandi C., Dose J., Schultheiss G., Rimbach G., Anti-inflammatory potential of allyl-isothiocyanate-role of Nrf2, NF- B and microRNA-155. Journal of Cellular and Molecular Medicine 2012 16 4 836 843 10.1111/j.1582-4934.2011.01367.x
121. Ernst I. M., Wagner A. E., Schuemann C., Storm N., Höppner W., Döring F., Stocker A., Rimbach G., Allyl-, butyl- and phenylethyl- isothiocyanate activate Nrf2 in cultured fibroblasts. Pharmacological Research 2011 63 3 233 240 2-s2.0-79751529435 10.1016/j.phrs.2010.11.005
122. Schumacker P. T., Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006 10 3 175 176 2-s2.0-33748165596 10.1016/j.ccr.2006.08.015 (Pubitemid 44311072)
123. Warburg O., On the origin of cancer cells. Science 1956 123 3191 309 314 2-s2.0-12444279265
124. Yoshii Y., Furukawa T., Yoshii H., Mori T., Kiyono Y., Waki A., Kobayashi M., Tsujikawa T., Kudo T., Okazawa H., Yonekura Y., Fujibayashi Y., Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism. Cancer Science 2009 100 5 821 827 2-s2.0-65349155747 10.1111/j.1349-7006.2009.01099.x
125. Simizu S., Takada M., Umezawa K., Imoto M., Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. Journal of Biological Chemistry 1998 273 41 26900 26907 2-s2.0-0032500543 10.1074/jbc.273.41.26900 (Pubitemid 28471710)
126. Fang J., Seki T., Maeda H., Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Advanced Drug Delivery Reviews 2009 61 4 290 302 2-s2.0-64149087422 10.1016/j.addr.2009.02.005
127. Raj L., Ide T., Gurkar A. U., Foley M., Schenone M., Li X., Tolliday N. J., Golub T. R., Carr S. A., Shamji A. F., Stern A. M., Mandinova A., Schreiber S. L., Lee S. W., Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011 475 7355 231 234 2-s2.0-79960427057 10.1038/nature10167
128. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., Chiao P. J., Achanta G., Arlinghaus R. B., Liu J., Huang P., Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β -phenylethyl isothiocyanate. Cancer Cell 2006 10 3 241 252 2-s2.0-33748146888 10.1016/j.ccr.2006.08.009 (Pubitemid 44311067)
129. Hail N. Jr., Cortes M., Drake E. N., Spallholz J. E., Cancer chemoprevention: a radical perspective. Free Radical Biology and Medicine 2008 45 2 97 110 2-s2.0-44649111827 10.1016/j.freeradbiomed.2008.04.004
130. Powolny A. A., Singh S. V., Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Letters 2008 269 2 305 314 2-s2.0-51349109112 10.1016/j.canlet.2008.05.027
131. Murata M., Yamashita N., Inoue S., Kawanishi S., Mechanism of oxidative DNA damage induced by carcinogenic allyl isothiocyanate. Free Radical Biology and Medicine 2000 28 5 797 805 2-s2.0-0034019294 10.1016/S0891-5849(00)00168-4 (Pubitemid 30171294)
132. Ahsan H., Hadi S. M., Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Letters 1998 124 1 23 30 2-s2.0-0032512698 10.1016/S0304-3835(97)00442-4 (Pubitemid 28073804)
133. Ghantous A., Gali-Muhtasib H., Vuorela H., Saliba N. A., Darwiche N., What made sesquiterpene lactones reach cancer clinical trials? Drug Discovery Today 2010 15 15-16 668 678 2-s2.0-77955517585 10.1016/j.drudis.2010.06.002
134. Singh N. P., Verma K. B., Case report of a laryngeal squamous cell carcinoma treated with artesunate. Archive of Oncology 2002 10 4 279 280 2-s2.0-0036975321 10.2298/AOO0204279S (Pubitemid 36164142)
135. Curry E. A. III, Murry D. J., Yoder C., Fife K., Armstrong V., Nakshatri H., O'Connell M., Sweeney C. J., Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Investigational New Drugs 2004 22 3 299 305 2-s2.0-3543018495 10.1023/B:DRUG.0000026256.38560.be (Pubitemid 39012569)
136. As M. L., Completed phase 2 clinical trials for parthenolide in treating allergic contact dermatitis. 2006, http://clinicaltrials.gov/ct2/show/ NCT00133341?term=Parthenolide&rank=1
137. Singh N. P., Panwar V. K., Case report of a pituitary macroadenoma treated with artemether. Integrative Cancer Therapies 2006 5 4 391 394 2-s2.0-33750858216 10.1177/1534735406295311 (Pubitemid 44722000)
138. Zhang Z.-Y., Yu S.-Q., Miao L.-Y., Huang X.-Y., Zhang X.-P., Zhu Y.-P., Xia X.-H., Li D.-Q., Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 2008 6 2 134 138 2-s2.0-39149087695 10.3736/jcim20080206 (Pubitemid 351255891)
139. Efferth T., Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin-from bench to bedside. Planta Medica 2007 73 4 299 309 2-s2.0-34250344275 10.1055/s-2007-967138 (Pubitemid 46910410)
140. Gill K. K., Kaddoumi A., Nazzal S., Mixed micelles of PEG2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. European Journal of Pharmaceutical Sciences 2012 46 1-2 64 71 2-s2.0-84859218842 10.1016/j.ejps.2012.02.010
141. Sohma I., Fujiwara Y., Sugita Y., Yoshioka A., Shirakawa M., Moon J.-H., Takiguchi S., Miyata H., Yamasaki M., Mori M., Doki Y., Parthenolide, an NF- B inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. Cancer Genomics and Proteomics 2011 8 1 39 47 2-s2.0-79951962599
142. Kreuger M. R., Grootjans S., Biavatti M. W., Vandenabeele P., D'herde K., Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anti-Cancer Drugs 2012 23 9 883 896
143. Ponka P., Beaumont C., Richardson D. R., Function and regulation of transferrin and ferritin. Seminars in Hematology 1998 35 1 35 54 2-s2.0-0031963449 (Pubitemid 28047041)
144. Harris E. D., Regulation of antioxidant enzymes. The FASEB Journal 1992 6 9 2675 2683 2-s2.0-0026634285
145. Gupte A., Mumper R. J., Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treatment Reviews 2009 35 1 32 46 2-s2.0-58549089871 10.1016/j.ctrv.2008.07.004
146. Coates R. J., Weiss N. S., Daling J. R., Rettmer R. L., Warnick G. R., Cancer risk in relation to serum copper levels. Cancer Research 1989 49 15 4353 4356 2-s2.0-0024371490 (Pubitemid 19207286)
147. Kwok J. C., Richardson D. R., The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Critical Reviews in Oncology/Hematology 2002 42 1 65 78 2-s2.0-0036118607 10.1016/S1040-8428(01) 00213-X (Pubitemid 34229148)
148. Wu T., Sempos C. T., Freudenheim J. L., Muti P., Smit E., Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Annals of Epidemiology 2004 14 3 195 201 2-s2.0-1342302879 10.1016/S1047-2797(03) 00119-4 (Pubitemid 38249333)
149. Kuo H. W., Chen S. F., Wu C. C., Chen D. R., Lee J. H., Serum and tissue trace elements in patients with breast cancer in Taiwan. Biological Trace Element Research 2002 89 1 1 11 2-s2.0-0036800770 10.1385/BTER:89:1:1 (Pubitemid 35222150)
150. Chan A., Wong F., Arumanayagam M., Serum ultrafiltrable copper, total copper and caeruloplasmin concentrations in gynaecological carcinomas. Annals of Clinical Biochemistry 1993 30 6 545 549 2-s2.0-0027429596 (Pubitemid 23344608)
151. Diez M., Arroyo M., Cerdan F. J., Munoz M., Martin M. A., Balibrea J. L., Serum and tissue trace metal levels in lung cancer. Oncology 1989 46 4 230 234 2-s2.0-0024356579 (Pubitemid 19160875)
152. Habib F. K., Dembinski T. C., Stitch S. R., The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates. Clinica Chimica Acta 1980 104 3 329 335 2-s2.0-0018817726 10.1016/0009-8981(80)90390-3 (Pubitemid 10070012)
153. Mazdak H., Yazdekhasti F., Movahedian A., Mirkheshti N., Shafieian M., The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group. International Urology and Nephrology 2010 42 1 89 93 2-s2.0-77950916395 10.1007/s11255-009-9583-4
154. Scanni A., Licciardello L., Trovato M., Tomirotti M., Biraghi M., Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung. Tumori 1977 63 2 175 180 2-s2.0-0017653360 (Pubitemid 8136921)
155. Zuo X. L., Chen J. M., Zhou X., Li X. Z., Mei G. Y., Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biological Trace Element Research 2006 114 1-3 41 54 2-s2.0-33846200852 10.1385/BTER:114:1:41 (Pubitemid 46094575)
156. Silva M. P., Soave D. F., Ribeiro-Silva A., Poletti M. E., Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescence. BMC Research Notes 2012 5 article 194 10.1186/1756-0500-5-194
157. Bryan S. E., Vizard D. L., Beary D. A., Labiche R. A., Hardy K. J., Partitioning of zinc and copper within subnuclear nucleoprotein particles. Nucleic Acids Research 1981 9 21 5811 5824 2-s2.0-0019878283 10.1093/nar/9.21.5811
158. Prousek J., Fenton chemistry in biology and medicine. Pure and Applied Chemistry 2007 79 12 2325 2338 2-s2.0-37149012352 10.1351/pac200779122325
159. Jeong J. B., Seo E. W., Jeong H. J., Effect of extracts from pine needle against oxidative DNA damage and apoptosis induced by hydroxyl radical via antioxidant activity. Food and Chemical Toxicology 2009 47 8 2135 2141 2-s2.0-68649087093 10.1016/j.fct.2009.05.034
160. Jeong J. B., De Lumen B. O., Jeong H. J., Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Letters 2010 293 1 58 64 2-s2.0-77952430321 10.1016/j.canlet.2009.12.019
161. Khokhar S., Apenten R. K. O., Iron binding characteristics of phenolic compounds: some tentative structure-activity relations. Food Chemistry 2003 81 1 133 140 2-s2.0-0037678581 10.1016/S0308-8146(02)00394-1 (Pubitemid 36801986)
162. Andjelković M., Camp J. V., Meulenaer B. D., Depaemelaere G., Socaciu C., Verloo M., Verhe R., Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chemistry 2006 98 1 23 31 2-s2.0-33644904982 10.1016/j.foodchem.2005.05.044
163. Ba Q., Zhou N., Duan J., Chen T., Hao M., Yang X., Li J., Yin J., Chu R., Wang H., Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS One 2012 7 8 e42703 10.1371/journal.pone.0042703
164. Merlot A. M., Kalinowski D. S., Richardson D. R., Novel chelators for cancer treatment: where are we now? Antioxid Redox Signal 2013 18 8 973 1006 10.1089/ars.2012.4540
165. Markova N. G., Karaman-Jurukovska N., Dong K. K., Damaghi N., Smiles K. A., Yarosh D. B., Skin cells and tissue are capable of using l-ergothioneine as an integral component of their antioxidant defense system. Free Radical Biology and Medicine 2009 46 8 1168 1176 2-s2.0-63049092997 10.1016/j.freeradbiomed. 2009.01.021
166. Zhu B.-Z., Mao L., Fan R.-M., Zhu J.-G., Zhang Y.-N., Wang J., Kalyanaraman B., Frei B., Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. Chemical Research in Toxicology 2011 24 1 30 34 2-s2.0-78651469381 10.1021/tx100214t
167. Halliwell B., Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radical Research 1999 31 4 261 272 2-s2.0-0032823769 10.1080/10715769900300841 (Pubitemid 29452853)
168. 2 formation. Carcinogenesis 1992 13 9 1497 1502 2-s2.0-0026732638
169. Yamashita N., Tanemura H., Kawanishi S., Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutation Research 1999 425 1 107 115 2-s2.0-0033065619 10.1016/S0027-5107(99)00029-9 (Pubitemid 29122033)
170. Bobrowska B., Skrajnowska D., Tokarz A., Effect of Cu supplementation on genomic instability in chemically-induced mammary carcinogenesis in the rat. Journal of Biomedical Science 2011 18 article 95 2-s2.0-84055223933 10.1186/1423-0127-18-95
171. Bobrowska-Korczak B., Skrajnowska D., Tokarz A., The effect of dietary zinc-and polyphenols intake on DMBA-induced mammary tumorigenesis in rats. Journal of Biomedical Science 2012 19 article 43 2-s2.0-84859728160 10.1186/1423-0127-19-43
172. Zheng L.-F., Wei Q.-Y., Cai Y.-J., Fang J.-G., Zhou B., Yang L., Liu Z.-L., DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radical Biology and Medicine 2006 41 12 1807 1816 2-s2.0-33751509078 10.1016/j.freeradbiomed.2006.09.007 (Pubitemid 44839142)
173. Halliwell B., Vitamin C: antioxidant or pro-oxidant in vivo? Free Radical Research 1996 25 5 439 454 2-s2.0-0029910233 (Pubitemid 26379060)
174. Rehman A., Collis C. S., Yang M., Kelly M., Diplock A. T., Halliwell B., Rice-Evans C., The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochemical and Biophysical Research Communications 1998 246 1 293 298 2-s2.0-0032496040 10.1006/bbrc.1998.8592 (Pubitemid 28413968)
175. Torshina N. R., Zhang J. Z., Heck D. E., Catalytic therapy of cancer with porphyrins and ascorbate. Cancer Letters 2007 252 2 216 224 2-s2.0-34249708326 10.1016/j.canlet.2006.12.026 (Pubitemid 46823948)
176. Torshina N. R., Zhang J. Z., Heck D. E., Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs. Evidence-Based Complementary and Alternative Medicine 2010 7 2 203 212 2-s2.0-77952133915 10.1093/ecam/nem159
177. Azmi A. S., Bhat S. H., Hanif S., Hadi S. M., Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. The FEBS Letters 2006 580 2 533 538 2-s2.0-30644475948 10.1016/j.febslet.2005.12.059 (Pubitemid 43089682)
178. Hadi S. M., Ullah M. F., Shamim U., Bhatt S. H., Azmi A. S., Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species. Chemotherapy 2010 56 4 280 284 2-s2.0-77955547212 10.1159/000319951
179. Khan H. Y., Zubair H., Ullah M. F., Ahmad A., Hadi S. M., Oral administration of copper to rats leads to increased lymphocyte cellular DNA degradation by dietary polyphenols: Implications for a cancer preventive mechanism. BioMetals 2011 24 6 1169 1178 2-s2.0-83555174405 10.1007/s10534-011- 9475-9
180. Zubair H., Khan H. Y., Ullah M. F., Ahmad A., Wu D., Hadi S. M., Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage. European Journal of Pharmaceutical Sciences 2012 47 1 280 286 10.1016/j.ejps.2012.04.014
181. Preston T. J., Henderson J. T., McCallum G. P., Wells P. G., Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2′- deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs. Molecular Cancer Therapeutics 2009 8 7 2015 2026 2-s2.0-61349196954 10.1158/1535-7163. MCT-08-0929
182. Das G. C., Bacsi A., Shrivastav M., Hazra T. K., Boldogh I., Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity. Molecular Carcinogenesis 2006 45 9 635 647 2-s2.0-33748809210 10.1002/mc.20184 (Pubitemid 44406634)
183. Glorieux C., Dejeans N., Sid B., Beck R., Calderon P. B., Verrax J., Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochemical Pharmacology 2011 82 10 1384 1390 2-s2.0-80054693822 10.1016/j.bcp.2011.06.007
184. Lau A., Villeneuve N. F., Sun Z., Wong P. K., Zhang D. D., Dual roles of Nrf2 in cancer. Pharmacological Research 2008 58 5-6 262 270 2-s2.0-56649083534 10.1016/j.phrs.2008.09.003
185. Sporn M. B., Liby K. T., NRF2 and cancer: the good, the bad and the importance of context. Nature Reviews Cancer 2012 12 8 564 571 10.1038/nrc3278
186. Ghaoui R., Sallustio B. C., Burcham P. C., Fontaine F. R., UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes. Chemico-Biological Interactions 2003 145 2 201 211 2-s2.0-0037422455 10.1016/S0009-2797(02)00253-3 (Pubitemid 36398433)
187. Sallustio B. C., Fishbein J. C., Glucuronidation-dependent toxicity and bioactivation. Advances in Molecular Toxicology 2008 2 Cambridge, Mass, USA Elsevier 57 86 10.1016/S1872-0854(07)02003-6
188. Sallustio B. C., Harkin L. A., Mann M. C., Krivickas S. J., Burcham P. C., Genotoxicity of acyl glucuronide metabolites formed from clofibric acid and gemfibrozil: a novel role for phase-II-mediated bioactivation in the hepatocarcinogenicity of the parent aglycones? Toxicology and Applied Pharmacology 1997 147 2 459 464 2-s2.0-0031422924 10.1006/taap.1997.8322 (Pubitemid 28062763)
189. Peddireddy V., Siva Prasad B., Gundimeda S. D., Penagaluru P. R., Mundluru H. P., Assessment of 8-oxo-7, 8-dihydro-2′-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer. Biomarkers 2012 17 3 261 268 2-s2.0-84860358440 10.3109/1354750X.2012.664169